Plasmodium falciparum:: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya:: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance

被引:29
作者
Mberu, EK
Nzila, AM
Nduati, E
Ross, A
Monks, SM
Kokwaro, GO
Watkins, WM
Sibley, CH
机构
[1] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA
[2] CGMRC, Kenya Med Res Inst, Wellcome Trust Collaborat Res Program, Nairobi, Kenya
[3] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA
[4] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England
[5] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
关键词
apicomplexa; malaria; drug resistance; DHPS; antifolate;
D O I
10.1016/S0014-4894(02)00108-X
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
We have determined the relationship between point mutations in the gene that encodes the sulfa target, dihydropteroate synthase (DHPS) and the chemosensitivity profile to sulfadoxine and dapsone in 67 isolates from Kilifi, Kenya. We assessed the presence of mutations at codons 436, 437, 540, 581, and 613 of dhps. The results showed that the dhps genotype had a strong influence on the sensitivity to sulfadoxine and dapsone, but that the correlation was far from perfect. Eleven isolates carried a wild-type dhps allele, but were resistant to sulfadoxine (IC50 values >10 mug/ml), and 4/28 isolates were classed as sensitive to sulfadoxine (IC50 values <10 μg/ml), but carried a triple mutant (436/437/613) allele of dhps. These data show that in low folate medium in vitro, the dhps genotype alone did not account completely for sulfadoxine or dapsone resistance; other factors such as the utilisation of exogenous folate must also be considered. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:90 / 96
页数:7
相关论文
共 39 条
[1]   Chlorproguanil-dapsone: Effective treatment for uncomplicated falciparum malaria [J].
Amukoye, E ;
Winstanley, PA ;
Watkins, WM ;
Snow, RW ;
Hatcher, J ;
Mosobo, M ;
Ngumbao, E ;
Lowe, B ;
Ton, M ;
Minyiri, G ;
Marsh, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) :2261-2264
[2]   Molecular epidemiology of malaria in Yaounde, Cameroon I.: Analysis of point mutations in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum [J].
Basco, LK ;
Ringwald, P .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 58 (03) :369-373
[3]  
BROCKELMAN CR, 1982, B WORLD HEALTH ORGAN, V60, P423
[4]   SYNERGISTIC ANTIMALARIAL ACTIVITY OF PYRIMETHAMINE AND SULFADOXINE AGAINST PLASMODIUM-FALCIPARUM INVITRO [J].
CHULAY, JD ;
WATKINS, WM ;
SIXSMITH, DG .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1984, 33 (03) :325-330
[5]  
COWMAN AF, 1997, MOD GENET, V3, P221
[6]   In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment [J].
Curtis, J ;
Duraisingh, MT ;
Warhurst, DC .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05) :1429-1433
[7]   MECHANISMS OF SULFADOXINE RESISTANCE IN PLASMODIUM-FALCIPARUM [J].
DIECKMANN, A ;
JUNG, A .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1986, 19 (02) :143-147
[8]   Plasmodium falciparum:: Detection of polymorphisms in the Dihydrofolate reductase and Dihydropteroate synthetase genes by PCR and restriction digestion [J].
Duraisingh, MT ;
Curtis, J ;
Warhurst, DC .
EXPERIMENTAL PARASITOLOGY, 1998, 89 (01) :1-8
[9]   THE DIHYDROFOLATE-REDUCTASE THYMIDYLATE SYNTHETASE GENE IN THE DRUG-RESISTANCE OF MALARIA PARASITES [J].
HYDE, JE .
PHARMACOLOGY & THERAPEUTICS, 1990, 48 (01) :45-59
[10]   Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda:: Correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes [J].
Jelinek, T ;
Kilian, AHD ;
Kabagambe, G ;
von Sonnenburg, F .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 61 (03) :463-466